10 TRILLION - yes TRILLION Calorie drop annually thanks to GLP-1 Meds like Semaglutide and Tirzepatide
- Oct 16, 2024
- 1 min read
Updated: Jul 22
Hey everyone — as clinic director I love sharing numbers that make people sit up, and this is a big one. (Full article linked at the bottom.)
Recent analysis looked at the impact of medications like Semaglutide and Tirzepatide on calorie consumption across the US — and estimated the collective drop at around 10 TRILLION calories annually. Ten. Trillion. That's not a typo.
Let me put that in perspective. That's the consumption equivalent of millions of people each cutting hundreds of calories a day, sustained, without the white-knuckle misery that normally comes with restriction. That's what "reduced appetite at scale" actually looks like when you zoom out to the population level.
Medications originally designed for diabetes are quietly reshaping the national calorie balance — and you're seeing the downstream effects everywhere: grocery stores reformulating products, restaurants adjusting portions, clothing retailers selling smaller sizes (we posted about that one too).
Here's why I share this beyond the wow factor: every one of those trillion calories represents the same thing we see in clinic — someone whose food noise finally went quiet enough to eat like a person instead of fighting a battle at every meal. The macro trend is just the sum of a million individual reliefs.
And this is still early days. Only a small fraction of eligible Americans are on these medications. The 10 trillion number? That's the beginning, not the peak.
-Daryl
Book a FREE consult now <- Click There!
www.pnwmedicalgroup.com
Puyallup: 253-340-2270
Federal Way: 253-363-8877



